CN105285647A - Black fungus extract solid beverage and preparation method thereof - Google Patents
Black fungus extract solid beverage and preparation method thereof Download PDFInfo
- Publication number
- CN105285647A CN105285647A CN201510593759.XA CN201510593759A CN105285647A CN 105285647 A CN105285647 A CN 105285647A CN 201510593759 A CN201510593759 A CN 201510593759A CN 105285647 A CN105285647 A CN 105285647A
- Authority
- CN
- China
- Prior art keywords
- black fungus
- fungus extract
- solid beverage
- activity
- extract solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000233866 Fungi Species 0.000 title claims abstract description 95
- 239000000284 extract Substances 0.000 title claims abstract description 85
- 235000013361 beverage Nutrition 0.000 title claims abstract description 60
- 239000007787 solid Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 14
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000010447 xylitol Nutrition 0.000 claims abstract description 14
- 239000000811 xylitol Substances 0.000 claims abstract description 14
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 14
- 229960002675 xylitol Drugs 0.000 claims abstract description 14
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 12
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 12
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 12
- 239000008187 granular material Substances 0.000 claims abstract description 7
- 239000002245 particle Substances 0.000 claims description 7
- 206010013786 Dry skin Diseases 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 abstract description 25
- 229920001282 polysaccharide Polymers 0.000 abstract description 25
- 239000005017 polysaccharide Substances 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 13
- 230000036039 immunity Effects 0.000 abstract description 10
- 230000002785 anti-thrombosis Effects 0.000 abstract description 7
- 230000000259 anti-tumor effect Effects 0.000 abstract description 6
- 239000003963 antioxidant agent Substances 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 3
- 239000008103 glucose Substances 0.000 abstract description 3
- 150000002632 lipids Chemical class 0.000 abstract description 3
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 238000003860 storage Methods 0.000 abstract description 3
- 230000001603 reducing effect Effects 0.000 abstract description 2
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 230000002019 anti-mutation Effects 0.000 abstract 1
- 230000003471 anti-radiation Effects 0.000 abstract 1
- 241000221377 Auricularia Species 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 235000000023 Auricularia auricula Nutrition 0.000 description 13
- 241001149430 Auricularia auricula-judae Species 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- 239000003146 anticoagulant agent Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000002218 hypoglycaemic effect Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000000055 hyoplipidemic effect Effects 0.000 description 5
- 230000002790 anti-mutagenic effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 241000221454 Auriculariaceae Species 0.000 description 2
- 241000221452 Auriculariales Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- IAJILQKETJEXLJ-KLVWXMOXSA-N (2s,3r,4r,5r)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid Chemical compound O=C[C@H](O)[C@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-KLVWXMOXSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001455 anti-clotting effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000004019 antithrombin Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- -1 cholesteryl ester Chemical class 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a black fungus extract solid beverage and a preparation method thereof. The black fungus extract solid beverage includes the following components in parts by weight: 1 part of black fungus extract and 2-15 parts of xylitol or maltodextrin. The black fungus extract solid beverage has a form of instant granules, and is convenient for use and carrying, accurate in dosage, stable in quality, and easy for storage and transportation. The black fungus extract solid beverage can better play the roles of black fungus polysaccharides in improving organism immunity, pharmacological activity, antithrombotic activity, blood glucose reducing activity, anti-tumor activity, anti-radiation activity and anti-mutation activity, antioxidant and anti-aging activity, and blood lipid lowering activity.
Description
Technical field
The present invention relates to a kind of solid beverage, particularly relate to a kind of black fungus extract solid beverage.
Background technology
Black fungus is the one belonged in auricularia auriculajudae, widely distributed in China, and autumn plucks.The edible mushroom that black fungus is nutritious, food flavor is delicious, still nutritive value is very not high, and be the medicinal fungus that medical value is higher.
Auricularia polysaccharide is one of active ingredient of Auricularia extract, there is pharmacological activity widely, comprise and improve immunity of organisms, pharmacologically active, antithrombotic acitivity, hypoglycemic activity, antitumor activity, radioresistance and antimutagenic activity, anti-oxidant and activity of fighting against senium, hypolipidemic activity etc.
At present, the beverage that existing Auricularia extract and Auricularia polysaccharide make, plays health-care effect, comprises and improves immunity, hypoglycemic, lipopenicillinase, the effect that delays senility.But current existing Auricularia polysaccharide beverage is liquid beverage, be inconvenient to transport and carry, and storage life is short.
The edible mushroom that black fungus is nutritious, food flavor is delicious, still nutritive value is very not high, and be the medicinal fungus that medical value is higher.Black fungus [Auriculariaauricular (L.exHook) Underw] belongs to Eumycota (Eumycophyta), Basidiomycotina (Basidiomycotina), Auriculariale (Auriculariales), Auriculariaceae (Auriculariaceae), Auricularia (Auricularia).Black fungus is the medicinal and edible fungi of China's preciousness, there is the effects such as beneficial gas is kept fit, filled blood, moistening lung, hemostasis, pain relieving, defaecation, be used for the treatment of hypertension, vascular sclerosis, menstruation, leukorrhea, have blood in stool, uterine hemorrhage, the many phlegm of gastric disorder causing nausea, haematemesis, constipation etc.Black fungus is the Typical Representative of " integration of drinking and medicinal herbs ", containing abundant polysaccharide, protein, amino acid, vitamin and microelement etc., have the good reputation of " element in meat or fish ".
Current auricularia auriculajudae concerned drink most for auricularia auriculajudae be primary raw material or auxiliary material, play fat-reducing, hypotensive, reducing blood lipid, the effect such as hypoglycemic, but the active ingredient in auricularia auriculajudae is not made further research, as number of patent application 200810005277.8, this patent is that primary raw material adopts water extract method to prepare extract with auricularia auriculajudae, granulates, filling capsule.In product auricularia auriculajudae prepared by the method, extracts active ingredients degree is not high, cannot give full play to the health-care effect of auricularia auriculajudae.
Scientific research proves, and in auricularia auriculajudae, active ingredient is mainly Auricularia polysaccharide, and Auricularia polysaccharide is one of important component of auricularia auriculajudae.In auricularia auriculajudae fructification, polysaccharide constituent is comparatively complicated, Misaki is by carrying out separation and purification to black fungus fructification, obtain four kinds of polysaccharide: FI-A, FI-B, FII and FIII [AkiraMisaki, MarikoKakuta, TakumaSasakietal.Studiesoninterrelationofstructureandant itumoreffectsofpolysaccharides:antitumoractionofperiodat emodified, branched (1 → 3)-β-D-glucanofAuriculariaAuricula-judae, andotherpolysaccharidescontaining (1 → 3) glycosidiclingkages [J] .CarbohydrateResearch, 1982, 92:115-120.].These four kinds of polysaccharide can be divided into acidic polysaccharose, water-soluble polysaccharide and water-insoluble polysaccharide again.FI-A and FII is acidic polysaccharose, have anticoagulation and antithrombotic acitivity [YoonSJ, PereiraMS,
mSG, HwangJK, PyunYR,
pAS.ThemedicinalplantPoranavolubiliscontainspolysacchari deswithanticoagulantactivitymediatedbyheparincofactorII. ThrombRes2002; 106:51 – 8.].Chen Zhiqiangs etc. adopt acid hydrolyzation to decompose Blackfungus polyhexose, by checking Rf value with monose sample, found that in polysaccharide sample main containing wood sugar, mannose, glucose, hexuronic acid, its mol ratio is 0.25:0.35:0.26:0.14 [Chen Zhiqiang, Shu Rong, Luo Chuanhuan. the preparation of Auricularia polysaccharide and Study On The Radioprotective experimental study [J]. Chinese Radiation Medicine and protection magazine, 2001,21 (1): 46.].Pereira etc. will have some polysaccharide or the polysaccharide analogs of anticoagulation and platelet aggregation inhibitory activity equally, also find under study for action, Blackfungus polyhexose contains glucuronic acid, but not sulfur-bearing acid esters [PereiraMS, MeloFR, MouraoPAS.Isthereacorrelationbetweenstructureandanticoag ulantactivityofsulfatedgalactansandsulfatedfucans [J] Glycobiology.2002; 12:573 – 80.].Morisaki etc. extract polysaccharide from black fungus fructification, through separation and purification, obtain two kinds of acid heteroglycans equally, be respectively MHA and MEA [MorisakiS, UkaiS.Polysaccharideinfungi VII AcidicHeteroglycansfromthefruitbodiesofAuriculariaAuricu lajudaequel [J] .ChemPharmBull, 1982,30 (2): 635-641].
Auricularia polysaccharide has many-side pharmacological action widely, is embodied as:
Improve immunity of organisms
The polysaccharide extracted from auricularia auriculajudae fructification, can stimulating immune system, has immunoregulation effect.Blackfungus polyhexose is by promoting human peripheral blood mononuclear cell proliferation, and the expression of the induction cytokine TNF relevant to body's immunity and IFN, thus enhanced machine body immunity function, improve anti-virus ability.Blackfungus polyhexose is by strengthening human thymocyte and this approach of spleen function enhancing cellular immune function.The black fungus extract of variable concentrations (50,100,150mg/kg) is given and is fed experiment mice by Zhang Huixin etc., successive administration 10 days, find that black fungus extract can significantly improve mouse spleen and thymus index, and the linear [Zhang Huixin of the dosage of the raising of Thymus and spleen index and black fungus extract, Liu Hongyu, Liu Chang, Liu Yufen. Blackfungus polyhexose is on the impact [J] of immune function of mice. and animal medicine is in progress, 2009,30 (7): 23-25.].Test mice macrophage phagocytic function significantly strengthens, and its phagocytic rate and phagocytic index are all better than control group mice.
Antithrombotic acitivity:
Seon-JooYoon [Seon-JooYoon, Myeong-AeYu, Yu-RyangPyun, Jae-KwanHwang, Djong-ChiChu, LekhRajJuneja, PauloA.S.Mourao.ThenontoxicmushroomAuriculariaauriculaco ntainsapolysaccharidewithanticoagulantactivitymediatedby antithrombin [J] .ThrombosisResearch, 2003 (112) 151 – 158.] etc. respectively comparatively deep research has been carried out to the extraction of Blackfungus polyhexose, qualification and Blackfungus polyhexose antithrombotic acitivity.By contrast, the Blackfungus polyhexose that buck extracts shows extremely significant anticoagulant active, similar with antiplatelet inhibitor aspirin.Seon-JooYoon infers that the possible anticlotting mechanism of Blackfungus polyhexose promotes that antithrombase is to the suppression of thrombin activity.In the experiment of Blackfungus polyhexose anti-platelet aggregation in vitro, play certain effect.
Hypoglycemic activity:
Zong Canhua etc. [Zong Canhua, Yu Guoping. Blackfungus polyhexose is to diabetic mice hypoglycemic activity [J]. edible mushroom, 2007 (4): 60-61.] have studied the hypoglycemic activity of Blackfungus polyhexose to normal group mouse and diabetic mice respectively.The mechanism that black fungus can reduce blood glucose in diabetic mice is because Blackfungus polyhexose can weaken alloxan to the damage of B cell or the function improving damaged cell, thus increases the secretion of insulin and blood sugar is reduced.
Antitumor activity:
[the Huang Binnan such as Huang Binnan, Zhang Xiujuan, Zou Xiang, draw cutting edge of a knife or a sword in morning. the research [J] of Blackfungus polyhexose antitumor action. Harbin University of Commerce's journal (natural science edition), 2004,20 (6): 648-651.] impact of Blackfungus polyhexose for the increase in life span of H22 tumor-bearing mice is studied.H22 carcinoma cell good for growth conditions is cultivated 7 days, is inoculated in mouse peritoneal, after 24 hours, give the Blackfungus polyhexose of mouse various dose.Contrast blank group H22 tumor-bearing mice time-to-live (about 10 days), Blackfungus polyhexose group mouse survival time significant prolongation, in dose-effect relationship, Blackfungus polyhexose group H22 tumor-bearing mice life extends at most 6 days (200mg/Kg), but because high dose group has higher toxic and side effect for mouse, finally determine that the optimal dose of Blackfungus polyhexose prolongation H22 tumor-bearing mice life span is 100mg/Kg.Above-mentioned experimental result also illustrates that Blackfungus polyhexose has certain tumor-inhibiting action from another point of view.
Radioresistance and antimutagenic activity
[the Tian Zhijie such as Tian Zhijie, Shen Nan, Lv Shijie, Wang Cheng, Jiang Yanxia, Luo Jun. Blackfungus polyhexose is on the impact [J] of intensive microwave irradiation rat blood serum superoxide dismutase and hepatic lipid peroxidation. time precious traditional Chinese medical science traditional Chinese medicines, 2009,20 (12): 3011-3013.] at research High-Power Microwave, (average surface power is greater than 10mW/cm
2) radiation resistance of radiation to superoxide dismutase and liver autooxidation and Blackfungus polyhexose time, find that Blackfungus polyhexose can improve superoxide dismutase in mice serum (SOD) activity and effectively reduce MDA (MDA) content in liver, and Blackfungus polyhexose has protective action to the body injury caused by High-Power Microwave, its prevention effect is obviously greater than its therapeutic action.
Anti-oxidant and activity of fighting against senium:
Experiment shows, Blackfungus polyhexose can improve the activity of the oxygen radical removing enzymes such as SOD, effectively prevents and treats the damage that the tissue such as cardiac muscle, liver is subject to because of anoxic, lipid peroxidation.
Hypolipidemic activity:
Blood fat is the general name of contained lipid in human plasma, comprising cholesterol, triglycerides, cholesteryl ester, beta lipoprotein, phosphatide, not esterified resin acid etc.When serum cholesterol exceedes normal value 230mg/100mL, triglycerides, more than 140mg/100mL, when beta lipoprotein is more than more than 390mg/100mL, can be referred to as hyperlipemia.The dominant mechanism that the high fat high cholesterol of too much absorption causes blood fat to increase is that cholesterol constantly produces cholic acid in metabolism, and participate in fat digest and assimilate process, thus cause hyperlipidemia.Hyperlipemia directly can cause the diseases such as thromboangiitis, obesity, atherosclerosis, fatty liver cholelithiasis and atherosclerotic coronary cardiopathy, threatens health.Black fungus Main Function is exactly can blood fat-reducing blood pressure-decreasing.The mechanism that black fungus has hypolipidemic activity is that black fungus can strengthen immunity of organisms, immunity moderation function, maintains the normal operation of each organ in human body, improves the activity participating in enzyme, promotes the normal circulation effect of liver and gall.Make various composition in blood fat reach normal condition like this, thus reduce blood fat accumulating amount in blood, ensure health.
Based on the above-mentioned raising immunity of organisms of Auricularia polysaccharide, pharmacologically active, antithrombotic acitivity, hypoglycemic activity, antitumor activity, radioresistance and antimutagenic activity, anti-oxidant and activity of fighting against senium, hypolipidemic activity, can obtain with Auricularia polysaccharide after being adopted by auricularia auriculajudae certain method to extract is the Auricularia extract of active ingredient, the exhibition direction, industry side that health drink is the industry is made with it, existing relevant patent application at present, as number of patent application 03119261.0, but be liquid beverage so far.Beverage is the drink often selected in people's daily life, on market, the existing agaric beverage that contains is liquid beverage at present, and nutritional labeling is single, is inconvenient to transport and carries, and the shelf-life is short, technology disclosed in number of patent application 201110240438.3, for taking auricularia auriculajudae as the liquid beverage of raw material, volume is large, weight is high, the shortcoming of inconvenient storage and transport, the shelf-life is shorter simultaneously, and generally the longest is 18 months.
Summary of the invention
The object of this invention is to provide a kind of black fungus extract solid beverage and preparation method, to overcome the defect that prior art exists, meet the needs of people.
Described black fungus extract solid beverage, comprises the component of following parts by weight:
Black fungus extract 1 part
Xylitol or maltodextrin 2 ~ 15 parts
Preferably, the component of following parts by weight is comprised:
Black fungus extract 1 part
Xylitol or maltodextrin 3 ~ 12 parts
Preferably, described black fungus extract solid beverage, comprises the component of following parts by weight:
Black fungus extract 1 part
Xylitol 6 ~ 10 parts
Preferably, described black fungus extract solid beverage, comprises the component of following parts by weight:
Black fungus extract 1 part
Maltodextrin 4 ~ 6 parts
Preferably, described black fungus extract solid beverage is particle, and particle diameter is 14 order ~ 40 orders;
Preferably, the bulk density 0.013g/cm of described black fungus extract solid beverage
3~ 0.030g/cm
3;
Term " bulk density " refers to a dust or powder is freely filled in a certain container, mass per volume measured after just having filled, the method that " GB/T16913.3-1997 dust physical property test method: the mensuration natural packing method of the 3rd part bulk density " can be adopted to specify detects;
The extracting method of described black fungus extract, can adopt the method for " research (Chen Yanqiu, Zhou Liping, Yin Yingmin) of black fungus fructification water-soluble polysaccharide extraction process " bibliographical information, or adopt following method:
Get black fungus and add 5-8 times of water (w/w), soak 1-2h, at 95-100 DEG C, boil 4-5h, extract, filter, in 60-80 DEG C of reduced pressure concentration, at being concentrated into 60 DEG C, proportion is 1.01-1.20g/cm
3, concentrate is cooled to room temperature, adds 2-3 times amount ethanol under stirring, leaves standstill, and filter, precipitates washed with EtOH, 60 ± 5 DEG C of vacuum drying, obtain black fungus extract, and main component is Auricularia polysaccharide;
The preparation method of described black fungus extract solid beverage, comprises the steps:
Mixed with xylitol or maltodextrin by described black fungus extract, granulate, 60 ± 5 DEG C of dryings, can obtain described black fungus extract solid beverage, when black fungus extract solid beverage and xylitol compatibility, are sweet taste; When black fungus extract solid beverage and maltodextrin compatibility, be original flavor, packing.
Eating of described black fungus extract solid beverage, very convenient, by the black fungus extract solid beverage obtained, mix with the water of 85 ~ 100 DEG C of temperature, stirring and dissolving, i.e. edible.
The invention has the beneficial effects as follows:
The form that the present invention is is instant granular, uses, easy to carry, and dosage is accurate, steady quality, easily stores and transport.The raising immunity of organisms of Auricularia polysaccharide, pharmacologically active, antithrombotic acitivity, hypoglycemic activity, antitumor activity, radioresistance and antimutagenic activity, anti-oxidant and activity of fighting against senium, hypolipidemic activity can better be played.
Detailed description of the invention
The extraction of black fungus extract:
Get black fungus and add 7 times of water (w/w), soak 1.5h, at 100 DEG C, boil 5h, filter, in 70 DEG C of reduced pressure concentrations, at being concentrated into 60 DEG C, proportion is 1.1g/cm
3, concentrate is cooled to room temperature, adds 2 times amount ethanol under stirring, leaves standstill, and filter, precipitates washed with EtOH, 60 ± 5 DEG C of vacuum drying, obtain black fungus extract, and main component is Auricularia polysaccharide.
Following embodiment, the black fungus extract for said method acquisition of employing.
Embodiment 1
Black fungus extract 1 part
Xylitol 10 parts
Preparation method:
Mixed with xylitol by described black fungus extract, granulate, 60 ± 5 DEG C of dryings, can obtain described black fungus extract solid beverage, be sweet taste;
Particle diameter is 40 orders, and bulk density is 0.029g/cm
3;
By the black fungus extract solid beverage obtained, mix with the water of 90 DEG C of temperature, stirring and dissolving, i.e. edible, the weight ratio of black fungus extract solid beverage and water is:
1 portion of black fungus extract solid beverage, 25 parts of water.
Solubility property detects:
Be that 90 DEG C of water mix by 1 portion of black fungus extract solid beverage and 25 parts of temperature, 200 revs/min, stir 1 minute, black fungus extract solid beverage all dissolves, without precipitation.
Storge quality detects:
After being adopted by black fungus extract solid beverage plastic-aluminum combined bag material to pack, be placed in the environment 540 days of 18 DEG C, without adhesion, good dispersion property.
Embodiment 2
Black fungus extract 1 part
Xylitol 8 parts
Preparation method:
Mixed with xylitol by described black fungus extract, granulate, 60 ± 5 DEG C of dryings, can obtain described black fungus extract solid beverage, be sweet taste;
Particle diameter is 40 orders, and bulk density is 0.030g/cm
3;
By the black fungus extract solid beverage obtained, mix with the water of 100 DEG C of temperature, stirring and dissolving, i.e. edible, the weight ratio of black fungus extract solid beverage and water is:
1 portion of black fungus extract solid beverage, 25 parts of water.
Solubility property detects:
Be that 100 DEG C of water mix by 1 portion of black fungus extract solid beverage and 40 parts of temperature, 200 revs/min, stir 1 minute, black fungus extract solid beverage all dissolves, without precipitation.
Storge quality detects:
After being adopted by black fungus extract solid beverage plastic-aluminum combined bag material to pack, be placed in the environment 700 days of 15 DEG C, without adhesion, good dispersion property.
Embodiment 3
Black fungus extract 1 part
Maltodextrin 5 parts
Preparation method:
Mixed with maltodextrin by described black fungus extract, granulate, 60 ± 5 DEG C of dryings, can obtain described black fungus extract solid beverage, be original flavor;
Particle diameter is 14 orders, and bulk density is 0.013g/cm
3;
By the black fungus extract solid beverage obtained, mix with the water of 95 DEG C of temperature, stirring and dissolving, i.e. edible, the weight ratio of black fungus extract solid beverage and water is:
1 portion of black fungus extract solid beverage, 25 parts of water.
Solubility property detects:
Be that 95 DEG C of water mix by 1 portion of black fungus extract solid beverage and 25 parts of temperature, 200 revs/min, stir 1 minute, black fungus extract solid beverage all dissolves, without precipitation.
Storge quality detects:
After being adopted by black fungus extract solid beverage plastic-aluminum combined bag material to pack, be placed in the environment 600 days of 20 DEG C, without adhesion, good dispersion property.
Claims (8)
1. black fungus extract solid beverage, is characterized in that, comprises the component of following parts by weight:
Black fungus extract 1 part
Xylitol or maltodextrin 2 ~ 15 parts.
2. black fungus extract solid beverage according to claim 1, is characterized in that, comprise the component of following parts by weight:
Black fungus extract 1 part
Xylitol or maltodextrin 3 ~ 12 parts.
3. black fungus extract solid beverage, is characterized in that, comprises the component of following parts by weight:
Black fungus extract 1 part
Xylitol 6 ~ 10 parts.
4. black fungus extract solid beverage, is characterized in that, comprises the component of following parts by weight:
Black fungus extract 1 part
Maltodextrin 4 ~ 6 parts.
5. the black fungus extract solid beverage described according to any one of Claims 1 to 4, is characterized in that, is particle, and particle diameter is 14 order ~ 40 orders.
6. the black fungus extract solid beverage described according to any one of Claims 1 to 4, is characterized in that, the bulk density 0.013g/cm of described black fungus extract solid beverage
3~ 0.030g/cm
3.
7. described black fungus extract solid beverage according to claim 5, is characterized in that, the bulk density 0.013g/cm of described black fungus extract solid beverage
3~ 0.030g/cm
3.
8. the preparation method of the black fungus extract solid beverage described according to any one of Claims 1 to 4, is characterized in that, comprise the steps:
Mixed with xylitol or maltodextrin by described black fungus extract, granulate, 60 ± 5 DEG C of dryings, can obtain described black fungus extract solid beverage.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510593759.XA CN105285647A (en) | 2015-09-17 | 2015-09-17 | Black fungus extract solid beverage and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510593759.XA CN105285647A (en) | 2015-09-17 | 2015-09-17 | Black fungus extract solid beverage and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105285647A true CN105285647A (en) | 2016-02-03 |
Family
ID=55184159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510593759.XA Pending CN105285647A (en) | 2015-09-17 | 2015-09-17 | Black fungus extract solid beverage and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105285647A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105901461A (en) * | 2016-04-11 | 2016-08-31 | 李宝山 | Fruit-flavor solid beverage and production method thereof |
| CN106360220A (en) * | 2016-08-31 | 2017-02-01 | 延边大学 | Black fungus-malt healthcare drink and preparation method thereof |
| CN106616943A (en) * | 2016-12-19 | 2017-05-10 | 黑龙江省科学院微生物研究所 | Instant black fungus nutrition paste and preparation method thereof |
| CN107028070A (en) * | 2017-06-09 | 2017-08-11 | 留坝县中药材发展办公室 | A kind of agaric solid beverage and preparation method thereof |
| CN107467668A (en) * | 2017-07-21 | 2017-12-15 | 哈尔滨工业大学 | A kind of compound Blackfungus polyhexose energy glue with radiation proof function prepares formula |
| CN107581543A (en) * | 2017-07-21 | 2018-01-16 | 哈尔滨工业大学 | A kind of hypoglycemic compound electuary |
| CN116114819A (en) * | 2022-12-01 | 2023-05-16 | 中华全国供销合作总社济南果品研究所 | Black fungus composite solid beverage and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102669785A (en) * | 2012-05-09 | 2012-09-19 | 陕西恒康生物科技有限公司 | Preparation method of instant functional solid beverage containing black fungus |
| CN104366640A (en) * | 2014-11-25 | 2015-02-25 | 呼伦贝尔蒙天源生物科技有限公司 | Preparation method of auricularia auricular polysaccharide beverage |
-
2015
- 2015-09-17 CN CN201510593759.XA patent/CN105285647A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102669785A (en) * | 2012-05-09 | 2012-09-19 | 陕西恒康生物科技有限公司 | Preparation method of instant functional solid beverage containing black fungus |
| CN104366640A (en) * | 2014-11-25 | 2015-02-25 | 呼伦贝尔蒙天源生物科技有限公司 | Preparation method of auricularia auricular polysaccharide beverage |
Non-Patent Citations (2)
| Title |
|---|
| 任文武等: "黑木耳饮料加工技术", 《农产品加工·学刊》 * |
| 徐秀忠等: "黑木耳多糖提取及多糖冲剂制备工艺研究", 《食品科技》 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105901461A (en) * | 2016-04-11 | 2016-08-31 | 李宝山 | Fruit-flavor solid beverage and production method thereof |
| CN106360220A (en) * | 2016-08-31 | 2017-02-01 | 延边大学 | Black fungus-malt healthcare drink and preparation method thereof |
| CN106616943A (en) * | 2016-12-19 | 2017-05-10 | 黑龙江省科学院微生物研究所 | Instant black fungus nutrition paste and preparation method thereof |
| CN106616943B (en) * | 2016-12-19 | 2020-07-21 | 黑龙江省科学院微生物研究所 | Instant black fungus nutritional paste and preparation method thereof |
| CN107028070A (en) * | 2017-06-09 | 2017-08-11 | 留坝县中药材发展办公室 | A kind of agaric solid beverage and preparation method thereof |
| CN107467668A (en) * | 2017-07-21 | 2017-12-15 | 哈尔滨工业大学 | A kind of compound Blackfungus polyhexose energy glue with radiation proof function prepares formula |
| CN107581543A (en) * | 2017-07-21 | 2018-01-16 | 哈尔滨工业大学 | A kind of hypoglycemic compound electuary |
| CN116114819A (en) * | 2022-12-01 | 2023-05-16 | 中华全国供销合作总社济南果品研究所 | Black fungus composite solid beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105285647A (en) | Black fungus extract solid beverage and preparation method thereof | |
| CN103054113B (en) | Composite fruit-vegetable juice beverage with blood sugar decreasing effect | |
| CN101850010B (en) | Active extract of citrus peels as well as extraction process and application thereof | |
| CN107114783A (en) | It is a kind of to strengthen the high selemium nutrition replenishers that immune and adjuvant therapy recovers | |
| CN112273649A (en) | Antioxidant and anti-aging composition, preparation method and application | |
| CN101664180A (en) | Health-care nutritional complexing agent with effect of and preparation method thereof | |
| KR20170099539A (en) | Sedum composition promoting antioxidant and alcohol oxidation | |
| CN102813209A (en) | Health-care food containing egg yolk lecithin, and preparation method thereof | |
| KR101859166B1 (en) | A composition for removing hangover comprising an herb extract including ginseng | |
| CN86101578A (en) | Chinese herbal medicine composite semipermeable membrane antistaling agent and manufacture method | |
| JP5160871B2 (en) | Lipid metabolism improver | |
| CN110302316A (en) | A kind of relieving alcoholism and protecting liver oral solution and preparation method | |
| CN103191081A (en) | Vitamin E soft capsules and preparation method thereof | |
| KR101992174B1 (en) | Tablet-type composition for preventing and relieving hangover, and protecting hepatic caused by alcohol containing medical herbs | |
| CN112076292A (en) | Powder with functions of enhancing immunity and regulating kidney yin deficiency and preparation method thereof | |
| CN107125376A (en) | A kind of Inonotus obliquus electuary（Tea） | |
| CN105533600A (en) | Ready-to-eat honey paste prepared from ginseng flowers and pollen pini and preparation method of honey paste | |
| WO2020052073A1 (en) | Extract for promoting lipid metabolism in liver, resisting inflammation and reducing enzyme content, and preparation method therefor | |
| CN104647881A (en) | Fruit juice milk tea with effects of dispelling effects of alcohol, protecting liver and nourishing stomach and preparation method thereof | |
| LU500683B1 (en) | Purpose of Composition Comprising Black Hulless Barley and Black Quinoa in Preparation of Anti-oxidation Products | |
| KR101173230B1 (en) | The components of anti-obesity and its modulation of allium tuberosum rottl. extracts and processed sulfur | |
| CN117084397A (en) | Composition for nourishing and protecting liver and preparation method thereof | |
| JPS61143324A (en) | Food for improving blood pressure and blood sugar level | |
| CN106606694A (en) | Health food for regulating blood fat | |
| CN104522238A (en) | Health-care piptoporus solonjensis tea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160203 |